Jefferies downgraded Bausch Health (BHC) to Hold from Buy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health call volume above normal and directionally bullish
- Bausch Health Retains Bausch + Lomb, Explores New Financial Strategies
- Bausch Health board determines not to move forward with Bausch + Lomb sale
- Bausch Health price target lowered to $10 from $11 at RBC Capital
- Bausch Health’s XIFAXAN Selected for Medicare Price Negotiation